<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03186599</url>
  </required_header>
  <id_info>
    <org_study_id>2016-0351</org_study_id>
    <nct_id>NCT03186599</nct_id>
  </id_info>
  <brief_title>Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer</brief_title>
  <official_title>Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gachon University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A trial will be conducted on 200 breast cancer patients with adjuvant hormonal therapy. The
      study included 6 months baseline measurement, and 12 months intervention. Patients will be
      assigned to high adherence or low adherence group. Then, through randomization, low adherence
      patients will be assigned to the intervention or control group. Study Coordinator delivers
      the intervention using the WALKON mobile application. Control participants receive usual care
      with continuous monitoring using Medication Event Monitoring System (MEMS) device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Baseline measurement (n=200): screening and enrollment

        -  3-month visit: collecting MEMS data

        -  6-month visit: collecting MEMS data and assigned to the high adherence (n=70) or low
           adherence group (n=75). The low adherence intervention group (n=75) will be educated
           about the WALKON mobile application.

        -  12-month visit: Control group: collecting MEMS data intervention group: monthly calls +
           collecting MEMS data

        -  18-month visit: collecting MEMS data and interview
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>physical activity (daily steps)</measure>
    <time_frame>12 months</time_frame>
    <description>Comparison of daily steps using WALKON application</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication adherence using MEMS device</measure>
    <time_frame>18 months</time_frame>
    <description>Comparison of adjuvant hormonal therapy adherence using MEMS device</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>high adherence control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>-Patients on continuous MEMS monitoring with usual care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low adherence control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>-Patients on continuous MEMS monitoring with usual care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low adherence intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient with the WALKON mobile application.
Patient with monthly feedback call
Patients on continuous MEMS monitoring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>low adherence intervention group</intervention_name>
    <description>Monthly, the study coordinator will give calls to encourage physical activities and medication adherence using MEMS and WALKON activity data.</description>
    <arm_group_label>low adherence intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage 0-III breast cancer

          -  Treated with Adjuvant hormonal therapy

        Exclusion Criteria:

          -  Stage IV breast cancer

          -  Breast cancer recurrence or metastasis

          -  Severe medical illness
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yul ha Min, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gachon University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yul ha Min, PhD</last_name>
    <phone>032-820-4227</phone>
    <email>yulha@gachon.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Sun Lee, RN</last_name>
      <phone>010-8964-9614</phone>
      <email>minsunlee1989@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2017</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>June 13, 2017</last_update_submitted>
  <last_update_submitted_qc>June 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gachon University</investigator_affiliation>
    <investigator_full_name>Yul Ha Min</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Medication Event Monitoring System</keyword>
  <keyword>adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

